home-hero.jpg

A Leading Outsourcing Partner to the pharmaceutical industry

Welcome to Dishman Carbogen Amcis Ltd!

We are a global outsourcing partner for pharmaceutical companies, offering a portfolio of products and development, scale-up and manufacturing services. The Dishman Group continually invests in the pharmaceutical industry, ensuring our businesses can provide pharmaceutical customers with high-value, high-quality products and services today and in the future. Our focus is to add value to the global pharmaceutical industry by serving as a reliable partner. We strongly believe that our business is successful only when our customers are successful.

Our Mission

The mission of Dishman Carbogen Amcis Ltd and its fundamental purpose is to offer support and assistance to people across the world suffering from illness and disease, striving to ensure that this is completed efficiently, comprehensively, and effectively.

Latest News

  • DCAL at iPHEX 2024 - India's Largest Global Pharmaceutical Exhibition

    New Delhi, INDIA (August 28 - 30, 2024) - We were thrilled to showcase our formulation business portfolio at India's most prestigious global pharmaceutical exhibition, the iPHEX 2024. Our team exhibited our key strengths in soft gel formulations comprising superior products catering to emerging health and wellness needs. They also gave customers an extensive overview of our core capabilities in Contract Research Manufacturing (CRM), Contract Development and Manufacturing (CDM), Contract Research (CRO), etc. 

    Read more

  • Dishman Carbogen Amcis Ltd receives 'Choose France - Best Indian Investment in France' award from the Indo French Chamber of Commerce and Industry (IFFCI)

    News

    Dishman Carbogen Amcis Ltd receives 'Choose France - Best Indian Investment in France' award from the Indo French Chamber of Commerce and Industry (IFFCI)

    NEW DELHI, India, (April 18, 2024) – Dishman Carbogen Amcis Ltd received the Choose France-Best Indian Investment in France award by the Indo French Chamber of Commerce & Industry in partnership with Business France India, at the sixth flagship event of the Indo-French Business Awards (IFBA) and Grand Prix VIE, in New Delhi. His Excellency Mr. Thierry Mathou, Ambassador of France presented the award which recognises Dishman’s investment in a new state-of-the-art...

    Read more

  • DCAL's Bavla plant gets PMDA approval

    News

    Dishman Carbogen Amcis Ltd awarded Certification of GMP Compliance by Japan’s Health Authority

    Gujarat, India - After a successful on-site inspection, Ahmedabad-based Dishman Carbogen Amcis Ltd (DCAL), receives the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) certification.

     

    DCAL’s drug substances manufacturing facility located in Bavla, underwent an inspection by the Japanese Health Authority. We are glad to announce that the inspection ended satisfactorily, and no major or critical...

    Read more

  • Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19

    News

    Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19

    Ahmedabad, India (December 9th, 2021) — Dishman Carbogen Amcis Ltd, a global outsourcing partner for the pharmaceutical industry, welcomes the results of a new Clinical Research Study which shows that oral 25-Hydroxyvitamin D3 (Calcifediol) was able to correct vitamin D deficiency/insufficiency in patients with COVID-19 and that it resulted in improved immune function by increasing...

    Read more

  • Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on study that uncovers treatment for vitamin D deficiency

    News

    Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on study that uncovers treatment for vitamin D deficiency

    Ahmedabad, India (May 21th, 2021) — India-based Dishman Carbogen Amcis Ltd, a global outsourcing partner for the pharmaceutical industry, welcomes the results of a new study that provides critical insights into the treatment of vitamin D deficiency in obesity and in fat malabsorption syndromes. The research was conducted by Boston University School of Medicine and supported in part by a grant from Dishman Carbogen Amcis Ltd’s wholly-owned...

    Read more

  • CARBOGEN AMCIS announces major investments of more than CHF 100 million in Switzerland and France

    News

    CARBOGEN AMCIS announces major investments of more than CHF 100 million in Switzerland and France

    BUBENDORF, Switzerland (August 17, 2020) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced today new expansion plans in Switzerland and France. 

    CARBOGEN AMCIS announces two major expansion projects that will increase manufacturing capacity to better meet the demands of the current market and its customers. The new facilities, located in Switzerland and France, will...

    Read more

    Upcoming events

      QUARTERNARY AMMONIUM SALTS EXPLAINED

      Dishman Carbogen Amcis Ltd. has rich expertise in Quaternary Ammonium Salts (Quats) with a robust and established portfolio. But do you know about their many benefits and applications? Watch the video to learn more about the Quats and discover how they could benefit you.

      Key Figures

      COVID-19 UPDATE

      As part of our commitment to continue the long fight against COVID-19, we have doubled the manufacturing capacity of some of our disinfectant API production facilities. Since March 2020, we have manufactured and globally exported more than 300 metric tons of disinfectant APIs.

      10 sites
      in India, Switzerland, UK, France, Netherlands & China
      30 years
      of experience in clinical API development
      100 metric tons
      scale manufacturing for API production
      1150 m3
      of capacity for API production
      300 metric tons
      of disinfectant APIs manufactured and exported to fight COVID-19 since 03/2020

      CONTACT US TODAY OR DOWNLOAD
      OUR COMPANY PROFILE BROCHURE
      FOR FURTHER INFORMATION

      SUBSCRIBE TO OUR MAILING LIST FOR THE LATEST NEWS UPDATES